Seasoned operator and investor specializing in growth-stage technology and consumer businesses. Megan Claucherty is an experienced executive with operating leadership, go-to-market scaling, and board roles; background spans product-led growth, commercial strategy, and post-investment value creation. Prior roles include senior operating positions and advisory work with venture and growth equity firms. Market-focused profile useful for LPs, corporate investors and portfolio companies seeking commercial scale expertise.
Seasoned operator and investor specializing in growth-stage technology and consumer businesses. Megan Claucherty is an experienced executive with operating leadership, go-to-market scaling, and board roles; background spans product-led growth, commercial strategy, and post-investment value creation. Prior roles include senior operating positions and advisory work with venture and growth equity firms. Market-focused profile useful for LPs, corporate investors and portfolio companies seeking commercial scale expertise.
Focuses on growth-stage technology and consumer investments, prioritizing companies with clear product-market fit and repeatable revenue models. Prefers revenue-led, unit-economics-driven underwriting and commits as an active, operator-investor to commercial value creation. Capital allocation emphasizes staged commitments with follow-on reserves for scaling leaders; time horizon typically mid-term growth (3–7 years). Risk discipline centers on customer retention, CAC payback and scalable go-to-market motion. Sector focus: SaaS, marketplaces, consumer tech; edge: hands-on go-to-market and board-level scaling execution.
Focuses on growth-stage technology and consumer investments, prioritizing companies with clear product-market fit and repeatable revenue models. Prefers revenue-led, unit-economics-driven underwriting and commits as an active, operator-investor to commercial value creation. Capital allocation emphasizes staged commitments with follow-on reserves for scaling leaders; time horizon typically mid-term growth (3–7 years). Risk discipline centers on customer retention, CAC payback and scalable go-to-market motion. Sector focus: SaaS, marketplaces, consumer tech; edge: hands-on go-to-market and board-level scaling execution.
| Trades 741 | Longs Won 432/741 58% | Profit Factor 3.22 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $10.06M |
| Average Win $5.76M | Best Trade (Oct 14) $108.39M | Sharpe Ratio -16.75 |
| Average Loss -$2.5M | Worst Trade (Sep 30) -$81.89M | Z-Score -1.95 (97.65%) |
| Commissions $0 | Avg. Trade Length 9m 1w 2d | Expectancy $2.32M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 1,342 | 1,208 | 1,074 | 940 | 805 | 671 | 537 | 403 | 268 | 134 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ABX Abacus Global Management, Inc. | 158,200 | $1.3M | $1.25M | - | -$52,209.69 | -4.01% | -0.253% |
ACAD Acadia Pharmaceuticals Inc. | 53,497 | $888,585 | $1.04M | - | $151,792.56 | 17.08% | -1.332% |
ADP Automatic Data Processing Inc. | 10,619 | $3.24M | $3.05M | - | -$198,203.57 | -6.11% | +0.425% |
AFRM Affirm Holdings, Inc. | 562,889 | $22.19M | $43.06M | - | $20.87M | 94.08% | +0.757% |
AGIO Agios Pharmaceuticals Inc. | 50,692 | $1.49M | $1.63M | - | $145,992.56 | 9.83% | -0.433% |
AJG Arthur J. Gallagher & Co. | 6,780 | $1.92M | $1.7M | - | -$220,994.13 | -11.48% | +0.462% |
ALGM Allegro MicroSystems, Inc. | 1.66M | $41.61M | $52.99M | - | $11.38M | 27.36% | -1.097% |
ALLY Ally Financial Inc. | 303,175 | $11.06M | $11.57M | - | $513,881.86 | 4.65% | +1.153% |
ALNY Alnylam Pharmaceuticals Inc | 21,159 | $5.71M | $5.03M | - | -$687,244.14 | -12.03% | +1.5% |
AMAT Applied Materials, Inc. | 195,034 | $28.3M | $82.41M | - | $54.11M | 191.17% | -1.735% |
AMBA Ambarella, Inc. | 904,536 | $53.93M | $56M | - | $2.07M | 3.83% | -2.27% |
AMPL Amplitude, Inc. | 138,316 | $1.41M | $2.11M | - | $700,570.58 | 49.71% | -3.632% |
AMTM Amentum Holdings, Inc. | 65,540 | $1.19M | $1.26M | - | $67,506.2 | 5.66% | +0.733% |
AMZN Amazon.com Inc | 199,140 | $40.69M | $50.47M | - | $9.78M | 24.03% | -0.524% |
BANC Banc of California Inc. | 205,185 | $2.91M | $3.58M | - | $667,877.31 | 22.94% | +1.189% |
BCRX BioCryst Pharmaceuticals Inc. | 468,799 | $3.52M | $3.72M | - | $199,239.05 | 5.67% | -1.185% |
BFH Bread Financial Holdings Inc. | 62,551 | $3.82M | $6.47M | - | $2.65M | 69.32% | +2.048% |
BKU BankUnited, Inc. | 493,194 | $16.99M | $20.74M | - | $3.76M | 22.11% | +0.107% |
BMRN Biomarin Pharmaceutical Inc. | 56,540 | $4M | $3.14M | - | -$858,277.6 | -21.47% | -0.963% |
CACI Caci International Inc. | 63,464 | $23.29M | $38.93M | - | $15.65M | 67.19% | +0.34% |